Healthcare Trust Of America (NYSE:HTA) Downgraded to Sell at ValuEngine

ValuEngine lowered shares of Healthcare Trust Of America (NYSE:HTA) from a hold rating to a sell rating in a research report report published on Thursday, ValuEngine reports.

A number of other brokerages have also issued reports on HTA. BTIG Research lowered Healthcare Trust Of America from a buy rating to a neutral rating in a research note on Monday, March 16th. JPMorgan Chase & Co. cut their price target on Healthcare Trust Of America from $33.00 to $27.00 and set an overweight rating for the company in a research note on Friday, April 3rd. Citigroup cut their price target on Healthcare Trust Of America from $34.00 to $25.00 and set a neutral rating for the company in a research note on Tuesday, April 7th. SunTrust Banks cut their price target on Healthcare Trust Of America from $33.00 to $27.00 and set a buy rating for the company in a research note on Thursday, April 23rd. Finally, Zacks Investment Research lowered Healthcare Trust Of America from a hold rating to a sell rating in a research report on Thursday, June 25th. Two analysts have rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average price target of $30.50.

Shares of HTA stock opened at $26.66 on Thursday. Healthcare Trust Of America has a 52-week low of $20.61 and a 52-week high of $34.22. The firm has a market capitalization of $5.82 billion, a PE ratio of 15.96 and a beta of 0.59. The stock has a fifty day simple moving average of $26.68 and a two-hundred day simple moving average of $28.16.

Healthcare Trust Of America (NYSE:HTA) last issued its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.41 by ($0.33). Healthcare Trust Of America had a return on equity of 1.71% and a net margin of 4.88%. The business had revenue of $185.78 million during the quarter, compared to analysts’ expectations of $182.57 million. During the same quarter in the previous year, the company posted $0.40 EPS. The company’s quarterly revenue was up 9.9% on a year-over-year basis. Equities analysts anticipate that Healthcare Trust Of America will post 1.66 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 9th. Stockholders of record on Thursday, July 2nd will be given a dividend of $0.315 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $1.26 dividend on an annualized basis and a dividend yield of 4.73%. Healthcare Trust Of America’s payout ratio is 76.83%.

In related news, CFO Robert A. Milligan purchased 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The stock was bought at an average price of $23.75 per share, for a total transaction of $47,500.00. Following the completion of the transaction, the chief financial officer now owns 170,212 shares in the company, valued at approximately $4,042,535. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.00% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Credit Suisse AG grew its position in Healthcare Trust Of America by 20.4% in the fourth quarter. Credit Suisse AG now owns 427,606 shares of the real estate investment trust’s stock worth $12,947,000 after acquiring an additional 72,366 shares in the last quarter. Guggenheim Capital LLC grew its position in Healthcare Trust Of America by 55.8% in the first quarter. Guggenheim Capital LLC now owns 216,330 shares of the real estate investment trust’s stock worth $5,252,000 after acquiring an additional 77,500 shares in the last quarter. Invesco Ltd. grew its position in Healthcare Trust Of America by 9.4% in the first quarter. Invesco Ltd. now owns 816,160 shares of the real estate investment trust’s stock worth $19,817,000 after acquiring an additional 70,017 shares in the last quarter. Janus Henderson Group PLC grew its position in Healthcare Trust Of America by 320.3% in the first quarter. Janus Henderson Group PLC now owns 43,693 shares of the real estate investment trust’s stock worth $1,061,000 after acquiring an additional 33,297 shares in the last quarter. Finally, Timbercreek Investment Management Inc. grew its position in Healthcare Trust Of America by 27.9% in the first quarter. Timbercreek Investment Management Inc. now owns 1,065,055 shares of the real estate investment trust’s stock worth $24,241,000 after acquiring an additional 232,614 shares in the last quarter. Institutional investors own 99.22% of the company’s stock.

About Healthcare Trust Of America

Healthcare Trust of America, Inc (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 23.2 million square feet of GLA, with $6.8 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.

See Also: Buy Rating

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Healthcare Trust Of America (NYSE:HTA)

Receive News & Ratings for Healthcare Trust Of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust Of America and related companies with MarketBeat.com's FREE daily email newsletter.